Provided by Tiger Trade Technology Pte. Ltd.

Tredegar

7.78
-0.1500-1.89%
Post-market: 7.780.00000.00%19:30 EDT
Volume:114.88K
Turnover:891.54K
Market Cap:271.61M
PE:8.13
High:7.92
Open:7.89
Low:7.67
Close:7.93
52wk High:10.53
52wk Low:6.25
Shares:34.91M
Float Shares:28.88M
Volume Ratio:0.62
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9572
EPS(LYR):0.9604
ROE:15.47%
ROA:6.50%
PB:1.19
PE(LYR):8.10

Loading ...

BRIEF-Tredegar Q1 Net Income From Continuing Operations USD 5 Million

Reuters
·
May 08

Tredegar Q1 FY26 net income rises to USD 5.07 million; sales climb 13.2% to USD 186.49 million

Reuters
·
May 08

Tredegar Reports First Quarter 2026 Results

THOMSON REUTERS
·
May 08

Tredegar: Conflict-Driven Disruptions in Strait of Hormuz Beginning in March 2026 Have Constrained Shipments and Raised Costs

THOMSON REUTERS
·
May 08

Tredegar Corp: Have Proactively Diversified Supply Chain Portfolio to Support Long-Term Stability

THOMSON REUTERS
·
May 08

Tredegar Corp: Are Optimizing Billet Casting Operations at Our Carthage, Tn, and Newnan, Ga Facilities to Overcome Localized Production Constraints.

THOMSON REUTERS
·
May 08

Tredegar: Through Q3 2026, Transitioned Nearly All of Aluminum Supply Previously Sourced From Middle East to North American Partners

THOMSON REUTERS
·
May 08

Tredegar Q1 Net Income From Cont Ops USD 5 Million

THOMSON REUTERS
·
May 08

Tredegar Q1 Adjusted EPS USD 0.15

THOMSON REUTERS
·
May 08

Tredegar Corp: Tariffs and Duties Continue to Be Passed Through to Customers Under Company's Metal‑Cost Adjustment Mechanism

THOMSON REUTERS
·
May 08

TG Therapeutics (TGTX) Q1 2026 Results Put 66% Net Margin Narrative To The Test

Simply Wall St.
·
May 08

TG Therapeutics price target raised to $70 from $60 at H.C. Wainwright

TIPRANKS
·
May 07

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX) and Insulet (PODD)

TIPRANKS
·
May 07

TG Therapeutics Up Over 14%, on Pace for Largest Percent Increase Since August 2024 -- Data Talk

Dow Jones
·
May 07

TG Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 07

TG Therapeutics Q1 Adj. EPS $0.18 Misses $0.30 Estimate, Sales $204.918M Beat $196.814M Estimate

Benzinga Earnings
·
May 06

Earnings Flash (TGTX) TG Therapeutics Posts Q1 EPS $0.12, vs. FactSet Est of $0.28

MT Newswires Live
·
May 06

TG-17 Reshapes Capital Structure with New Financing Terms

TIPRANKS
·
May 04

Amarin Reports 2026 First Quarter Financial Results

GlobeNewswire
·
Apr 29

TG Metals boosts Van Uden gold resource and advances lithium processing technology

TIPRANKS
·
Apr 28